Kawasaki Disease (Mucocutaneous Lymph Node Syndrome)
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect
Treatment of Kawasaki disease | Download Table
Lightning Learning: Kawasaki Disease — EM3
Treatment Options for Refractory Kawasaki Disease
Diagnosis and Management of Kawasaki Disease | AAFP
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Clinical Practice Guidelines : Kawasaki disease
Diagnosis and Management of Kawasaki Disease | AAFP
Kawasaki Disease: Complications and Treatment | American Heart Association
Kawasaki Disease Symptoms | Kawasaki Kids Foundation
Kawasaki disease: an update on diagnosis and treatment. | Semantic Scholar
Autoimmune Diseases: Kawasaki Disease - Healthway Medical
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Kawasaki Disease: An Update on Diagnosis and Treatment - ScienceDirect
Kawasaki Disease From COVID-19 in Kids: How Common? | MedPage Today
Kawasaki Disease: Signs, Symptoms and Diagnosis | American Heart Association
